369 related articles for article (PubMed ID: 14993494)
1. Structural alterations to the podocyte are related to proteinuria in type 2 diabetic patients.
White KE; Bilous RW;
Nephrol Dial Transplant; 2004 Jun; 19(6):1437-40. PubMed ID: 14993494
[TBL] [Abstract][Full Text] [Related]
2. Podocyte detachment and reduced glomerular capillary endothelial fenestration in human type 1 diabetic nephropathy.
Toyoda M; Najafian B; Kim Y; Caramori ML; Mauer M
Diabetes; 2007 Aug; 56(8):2155-60. PubMed ID: 17536064
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of atubular glomeruli in type 2 diabetic patients with nephropathy.
White KE; Marshall SM; Bilous RW
Nephrol Dial Transplant; 2008 Nov; 23(11):3539-45. PubMed ID: 18558622
[TBL] [Abstract][Full Text] [Related]
4. Podocyte lesions in patients with obesity-related glomerulopathy.
Chen HM; Liu ZH; Zeng CH; Li SJ; Wang QW; Li LS
Am J Kidney Dis; 2006 Nov; 48(5):772-9. PubMed ID: 17059996
[TBL] [Abstract][Full Text] [Related]
5. Structural involvement in type 1 and type 2 diabetic nephropathy.
Dalla Vestra M; Saller A; Bortoloso E; Mauer M; Fioretto P
Diabetes Metab; 2000 Jul; 26 Suppl 4():8-14. PubMed ID: 10922968
[TBL] [Abstract][Full Text] [Related]
6. The podocyte: a major player in the development of diabetic nephropathy?
Marshall SM
Horm Metab Res; 2005 Apr; 37 Suppl 1():9-16. PubMed ID: 15918105
[TBL] [Abstract][Full Text] [Related]
7. Potential role of angiotensin-converting enzyme inhibitors and statins on early podocyte damage in a model of type 2 diabetes mellitus, obesity, and mild hypertension.
Blanco S; Vaquero M; Gómez-Guerrero C; López D; Egido J; Romero R
Am J Hypertens; 2005 Apr; 18(4 Pt 1):557-65. PubMed ID: 15831368
[TBL] [Abstract][Full Text] [Related]
8. Intra-renal and urinary mRNA expression of podocyte-associated molecules for the estimation of glomerular podocyte loss.
Wang G; Lai FM; Lai KB; Chow KM; Kwan BC; Li KT; Szeto CC
Ren Fail; 2010 Jan; 32(3):372-9. PubMed ID: 20370455
[TBL] [Abstract][Full Text] [Related]
9. Thin glomerular basement membrane in diabetic patients with urinary abnormalities.
Matsumae T; Fukusaki M; Sakata N; Takebayashi S; Naito S
Clin Nephrol; 1994 Oct; 42(4):221-6. PubMed ID: 7834913
[TBL] [Abstract][Full Text] [Related]
10. Ultrastructural changes in the glomerular filtration barrier and occurrence of proteinuria in Chinese patients with type 2 diabetic nephropathy.
Zhu WW; Chen HP; Ge YC; Xie HL; Zeng CH; Li LS; Liu ZH
Diabetes Res Clin Pract; 2009 Dec; 86(3):199-207. PubMed ID: 19815303
[TBL] [Abstract][Full Text] [Related]
11. Research into the glomerular podocyte--is it relevant to diabetic nephropathy?
White KE
Diabet Med; 2006 Jul; 23(7):715-9. PubMed ID: 16842474
[TBL] [Abstract][Full Text] [Related]
12. Podocytes are firmly attached to glomerular basement membrane in kidneys with heavy proteinuria.
Lahdenkari AT; Lounatmaa K; Patrakka J; Holmberg C; Wartiovaara J; Kestilä M; Koskimies O; Jalanko H
J Am Soc Nephrol; 2004 Oct; 15(10):2611-8. PubMed ID: 15466265
[TBL] [Abstract][Full Text] [Related]
13. The podocyte and diabetes mellitus: is the podocyte the key to the origins of diabetic nephropathy?
Reddy GR; Kotlyarevska K; Ransom RF; Menon RK
Curr Opin Nephrol Hypertens; 2008 Jan; 17(1):32-6. PubMed ID: 18090667
[TBL] [Abstract][Full Text] [Related]
14. Role of mesangial expansion in the pathogenesis of diabetic nephropathy.
Dalla Vestra M; Saller A; Mauer M; Fioretto P
J Nephrol; 2001; 14 Suppl 4():S51-7. PubMed ID: 11798146
[TBL] [Abstract][Full Text] [Related]
15. Analysis of NO-synthase expression and clinical risk factors in human diabetic nephropathy.
Hohenstein B; Hugo CP; Hausknecht B; Boehmer KP; Riess RH; Schmieder RE
Nephrol Dial Transplant; 2008 Apr; 23(4):1346-54. PubMed ID: 18065828
[TBL] [Abstract][Full Text] [Related]
16. Complete remission of diabetic nephropathy in a type 1 diabetic patient with near-nephrotic range proteinuria and reduced renal function.
Haraguchi K; Hara S; Ubara Y; Tanaka S; Nukui I; Shimura H; Ohashi K; Kobayashi T
Diabetes Res Clin Pract; 2009 Mar; 83(3):295-9. PubMed ID: 19162360
[TBL] [Abstract][Full Text] [Related]
17. Messenger RNA expression of podocyte-associated molecules in the urinary sediment of patients with diabetic nephropathy.
Wang G; Lai FM; Lai KB; Chow KM; Li KT; Szeto CC
Nephron Clin Pract; 2007; 106(4):c169-79. PubMed ID: 17596726
[TBL] [Abstract][Full Text] [Related]
18. Are glomerular lesions alternatives to microalbuminuria in predicting later progression of diabetic nephropathy?
Shoji T; Kanda T; Nakamura H; Hayashi T; Okada N; Nakanishi I; Shimizu Y; Tsubakihara Y
Clin Nephrol; 1996 Jun; 45(6):367-71. PubMed ID: 8793227
[TBL] [Abstract][Full Text] [Related]
19. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy.
Susztak K; Raff AC; Schiffer M; Böttinger EP
Diabetes; 2006 Jan; 55(1):225-33. PubMed ID: 16380497
[TBL] [Abstract][Full Text] [Related]
20. Lack of {alpha}8-integrin aggravates podocyte injury in experimental diabetic nephropathy.
Hartner A; Cordasic N; Menendez-Castro C; Volkert G; Yabu JM; Kupraszewicz-Hutzler M; Rascher W; Hilgers KF
Am J Physiol Renal Physiol; 2010 Nov; 299(5):F1151-7. PubMed ID: 20826576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
